The effect of antihypertensives, amlodipine and telmisartan, on serum visfatin and insulin resistance in patients with essential hypertension with and without insulin resistance.

Trial Profile

The effect of antihypertensives, amlodipine and telmisartan, on serum visfatin and insulin resistance in patients with essential hypertension with and without insulin resistance.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Dec 2011

At a glance

  • Drugs Amlodipine (Primary) ; Telmisartan (Primary)
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top